Your allergy
What is allergy
House dust mite allergy
Pollen allergy
Living with allergy
Socio-economic impact
What is allergic asthma
How is allergy diagnosed
Treating allergy
Our solutions
Consumer healthcare
Diagnostics
Allergy vaccines
Production and quality
Emergency medicine
Our science
Scientific focus
Science & technology
Pipeline
Digital innovation
Collaboration & partnerships
Healthcare Professionals
Symposium on Specific Allergy
Henning Løwenstein Research Award
Our company
Press
Our strategy
Our leadership
Our history
Corporate governance
Sustainability
Environmental
Social
Governance
Investors
Overview
Financial reporting
Risk management
Reporting standards
Auditors
Governance
IR policy
Executive Leadership Team
Board of directors
News & Events
Company releases
Company releases (DK)
Webcasts & presentations
Investor calendar
Capital Markets Day 2024
The Share
Dividend history
Analyst coverage
Analyst estimates
Shareholder information
Authorizations
ADR Programme
Contact IR
Annual general meeting
Annual general meeting (DK)
Capital Markets Day 2024
Careers
Current job opportunities
This is ALK
A culture of collaboration and inclusion
Meet your future colleagues
Meet our leaders
Select country
Fulltext search
Search
Associate Director Medical Affairs, Benelux
Read more
about Associate Director Medical Affairs, Benelux
EasyCruit ID
3615079
Department ID
109011
Location
Almere, Netherlands
Vacancy URL
https://alkabello.easycruit.com/vacancy/3615079/109011
Expire Date
Tue, 06/30/2026 - 12:00
Last updated:
08.04.2026
Grant of share-based long-term incentive instruments to members of the Board of Management and key employees
Read more
about Grant of share-based long-term incentive instruments to members of the Board of Management and key employees
Link
https://www.globenewswire.com/news-release/2026/04/01/3266347/0/en/Grant-of-sha…
Created date
Wed, 04/01/2026 - 12:00
Nasdaq ID
3266347
Last updated:
01.04.2026
Key Account Specialist
Read more
about Key Account Specialist
EasyCruit ID
3600177
Department ID
160431
Location
Kraków, Poland
Vacancy URL
https://alkabello.easycruit.com/vacancy/3600177/160431
Expire Date
Sun, 05/31/2026 - 12:00
Last updated:
01.04.2026
Fullstack .NET Developer with AI
Read more
about Fullstack .NET Developer with AI
EasyCruit ID
3613017
Department ID
214681
Location
Kraków, Poland
Vacancy URL
https://alkabello.easycruit.com/vacancy/3613017/214681
Expire Date
Tue, 06/30/2026 - 12:00
Last updated:
31.03.2026
EURneffy 1 mg approved across the EU as the first and only needle-free adrenaline treatment for young children (≥15 kg) at risk of anaphylaxis
Read more
about EURneffy 1 mg approved across the EU as the first and only needle-free adrenaline treatment for young children (≥15 kg) at risk of anaphylaxis
Link
https://www.globenewswire.com/news-release/2026/03/31/3265184/0/en/EURneffy-1-m…
Created date
Tue, 03/31/2026 - 12:00
Nasdaq ID
3265184
Last updated:
31.03.2026
Country Sales Manager Sweden
Read more
about Country Sales Manager Sweden
EasyCruit ID
3610983
Department ID
115073
Location
Kungsbacka, Sweden
Vacancy URL
https://alkabello.easycruit.com/vacancy/3610983/115073
Expire Date
Sun, 05/31/2026 - 12:00
Last updated:
27.04.2026
Senior Tracking & Analytics Specialist
Read more
about Senior Tracking & Analytics Specialist
EasyCruit ID
3610471
Department ID
220831
Location
Kraków, Poland
Vacancy URL
https://alkabello.easycruit.com/vacancy/3610471/220831
Expire Date
Sun, 05/31/2026 - 12:00
Last updated:
27.04.2026
Annual General Meeting in ALK-Abelló A/S held on 16 March 2026
Read more
about Annual General Meeting in ALK-Abelló A/S held on 16 March 2026
Link
https://www.globenewswire.com/news-release/2026/03/16/3256594/0/en/Annual-Gener…
Created date
Mon, 03/16/2026 - 12:00
Nasdaq ID
3256594
Last updated:
16.03.2026
Senior HRIS Workday Specialist
Read more
about Senior HRIS Workday Specialist
EasyCruit ID
3606421
Department ID
167763
Location
Kraków, Poland
Vacancy URL
https://alkabello.easycruit.com/vacancy/3606421/167763
Expire Date
Tue, 06/30/2026 - 12:00
Last updated:
08.04.2026
New data reveals 9 in 10 people prefer EURneffy, a needle-free nasal adrenaline spray, over auto-injectors
Read more
about New data reveals 9 in 10 people prefer EURneffy, a needle-free nasal adrenaline spray, over auto-injectors
Link
https://www.globenewswire.com/news-release/2026/03/04/3249131/0/en/New-data-rev…
Created date
Wed, 03/04/2026 - 12:00
Nasdaq ID
3249131
Last updated:
04.03.2026
Pagination
First page
« First
Previous page
‹ Previous
Page
1
Page
2
Page
3
Current page
4
Page
5
Page
6
Page
7
Page
8
Page
9
…
Next page
Next ›
Last page
Last »
Subscribe to